Table 4.
Multivariate analysis of cancer-specific mortality
| Variable | HR | 95% CI | p |
|---|---|---|---|
|
Age |
0.987* |
0.942-1.033 |
0.567 |
|
RP |
|
|
Reference |
|
IMRT |
1.706 |
0.730-3.987 |
0.218 |
|
DRE T1-T2a |
|
|
Reference |
|
DRE T2b-T2c |
5.674 |
2.205-14.599 |
0.001 |
|
DRE ≥ T3 |
8.380 |
3.179-22.091 |
0.001 |
|
Gleason score ≤6 |
|
|
Reference |
|
Gleason score =7 |
1.397 |
0.512-3.810 |
0.514 |
|
Gleason score ≥8 |
7.183 |
2.777-18.574 |
0.001 |
|
PSA ≤ 10 ng/mL |
|
|
Reference |
|
PSA > 10 and ≤20 ng/mL |
0.333 |
0.111-0.994 |
0.049 |
| PSA > 20 ng/mL | 0.984 | 0.427-2.268 | 0.971 |
*HR for age expressed per year increase.